James M. Pluda - Concepedia

Author

James M. Pluda

Also Known As

J M Pluda, J PLUDA, J Pluda, J. M. Pluda, J. Pluda, J.M. Pluda, JAMES M. PLUDA, James M Pluda, James M. Pluda, James Pluda

111

Publications

7.9K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Center for Cancer Research National Institutes of Health Clinical Center

About

James M. Pluda is an author at National Cancer Institute specializing in medicine, pharmacology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	25	1.8K
2	Health Sciences	1	1	129
3	Natural Sciences	1	1	28
4	Biochemistry	1	1	28
5	Biomedical Engineering	1	1	93

James M. Pluda

Publications

7.2K

Citations

H-Index

Page 1

	Year	Citations
Phase II Trial of the Antiangiogenic Agent Thalidomide in Patients With Recurrent High-Grade Gliomas Howard A. Fine, William D. Figg, Kurt A. Jaeckle, Journal of Clinical Oncology	2000	425
In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-Dideoxyinosine Robert Yarchoan, Hiroaki Mitsuya, Rose V. Thomas, Science	1989	425
A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer. W D Figg, William Dahut, Paul H. Duray, PubMed	2001	304
Activity of Thalidomide in AIDS-Related Kaposi’s Sarcoma Richard F. Little, Kathleen M. Wyvill, James M. Pluda, Journal of Clinical Oncology Primary ImmunodeficiencyMedian Thalidomide DoseOncologyMedicineMetronomic Therapy	2000	290
Phase I Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors Roy S. Herbst, Kenneth R. Hess, Hai T. Tran, Journal of Clinical Oncology	2002	277
Development of Non-Hodgkin Lymphoma in a Cohort of Patients with Severe Human Immunodeficiency Virus (HIV) Infection on Long-Term Antiretroviral Therapy James M. Pluda Annals of Internal Medicine	1990	272
Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies. James M. Pluda PubMed	1997	243
Phase I Pharmacokinetic and Pharmacodynamic Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors James P. Thomas, Rhoda Arzoomanian, Dona Alberti, Journal of Clinical Oncology	2003	226
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma. H. S. Friedman, Demetrius M. Kokkinakis, James M. Pluda, Journal of Clinical Oncology	1998	216
Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complex Robert Yarchoan, James M. Pluda, Rose V. Thomas, The Lancet MedicineImmunologyLong-term Toxicity/activity ProfileToxicologyAntimicrobial Chemotherapy	1990	215

Page 1